, mainly due to defective IL-17 immunity [43, 44], mediated by eliciting production of autoantibodies (AAs) against IL-17, IL-17F, and IL-22 that contribute to chronic mucocutaneous candidiasis [45, 46]. This evidence concerns the gene IL17A and chronic mucocutaneous candidiasis.